Baseline prognostic factors and statistic model to predict early virological response in lamivudine-treated patients with chronic hepatitis B

Lamivudine is a potent nucleoside analogue used in treating chronic hepatitis B (CHB). However, resistance to the drug remains a problem. We analyzed all lamivudine recipients in this trial to determine the baseline characteristics and a model to predict early virological response reflecting the lon...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Clin Exp Med
Autori principali: Zhou, Rui, Pan, Fan, Lin, Chun, Lin, Xiuquan, Gao, Haibing, Huang, Shuiwen, Huang, Zuxiong, Lin, Yong, Pan, Chen, Zhou, Yuanping
Natura: Artigo
Lingua:Inglês
Pubblicazione: e-Century Publishing Corporation 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694462/
https://ncbi.nlm.nih.gov/pubmed/26770562
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi